Quick access

target-therapy

Spatially targeted eradication of antimicrobial-resistant bacteria

News

Mise à jour le   10/08/2022

News Feed

 

Job Offers

All three Ph.D. positions (in Siegen) and a post-doctoral position (in Brest) have been filled. One post-doctoral position (in Reims) is still opened.

Read more

Publications and Communications

Follow latest productions by TTP.

Read more

Main Meetings

In addition to formal meetings and status calls, subgroup meetings (not mentioned hereafter) are also done on a regular basis. 

Related files and documents are available via a password-secured intranet.

 

  • October 2022: Plenary “in person” meeting in Brest

Details to be set up soon.

  • January 11 2022: Status call

Meeting purposes: Update about the progress of TTP, 9 months and a half of the start of the project.

  • April 21 2022: Status call

Meeting purposes: Update about the progress of TTP, 12 months and a half of the start of the project.

Meeting purposes: Discussion about fiber optic options for doing illumination in mice airways.

Due to COVID19 restrictions, all our planned meetings and workshops were done online.

  • January 26 2021: Preparatory meeting

This meeting aimed to prepare the start of Target Therapy project.

  • April 9 2021: TTP Kick-off meeting

Target Therapy project was officially launched on April 2021!

  • April 22 2021: AMR.2 Kick-off meeting

Each funded project of the “2nd French-German call for projects on antimicrobial resistance 2020” was presented during that meeting.

  • October 10 2021: Plenary meeting

Meeting purposes: Current state of TTP, 7 months of the start of the project; Next plans and timelines.

  • November 18 2021: Status call

Meeting purposes: Update about the progress of TTP, 8 months of the start of the project.

Last Highligthed Events

10-August-2022

 

TTP just published another article.

It is in open-access and can be read here: https://www.mdpi.com/1999-4923/14/8/1664

31-May-2022

 

Dr Mareike Müller gave an interview for the Mukoviszidose e. V. about "My CF story"

Read more here: https://blog.muko.info/meine-cf-geschichte-dr-mueller/

20-April-2022

 

Mr Adeel NASIR just joined this month the TARGET-THERAPY consortium. As a Postdoctoral fellow working for 2 years in Partner P1 team, he will participate in biological evaluations under in vitro and in vivo settings.

 

Welcome Adeel and best wishes with great success!

Agenda

Septembre

Aucun événement ce mois

Octobre

Du 4 octobre au 5 octobre 2022

TARGET-THERAPY Plenary Meeting in Brest

Novembre

Aucun événement ce mois